Gadoteric acid

This classification denotes a gadolinium contrast media with the molecular formula C16H24N4O8.H+.Gd, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QVF9Y6955W, chemically known as hydrogen (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetato(4-))gadolinate(1-). but more generally known as gadoteric acid, which bears U.S. National Institutes of Health Compound Identifier 3085828. The European Medicines Agency schedules Gadoteric acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07865MIG. The World Health Organization schedules gadoteric acid in its Anatomical Therapeutic Chemical (ATC) Classification. SMILES: [Gd].OC(=O)CN1CCN(CCN(CCN(CC1)CC(=O)O)CC(=O)O)CC(=O)O. Most nations schedule Gadoteric acid under HS 28469000.